Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil infusion for tracheal extubation and emergence after anesthesia
IRCT201309074005N9Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- May 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of remifentanil, sponsored by Tabriz University of Medical Sciences. Started May 2013; status: completed.
02
Drugs
remifentanil
Beyond the preview
Go deeper on IRCT201309074005N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201309074005N9.